Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

  • Nakanishi, Tomoko
  • Pigazzini, Sara
  • Degenhardt, Frauke
  • Cordioli, Mattia
  • Butler-Laporte, Guillaume
  • Maya-Miles, Douglas
  • Nafría-Jiménez, Beatriz
  • Bouysran, Youssef
  • Niemi, Mari
  • Palom, Adriana
  • Ellinghaus, David
  • Khan, Atlas
  • Martínez-Bueno, Manuel
  • Rolker, Selina
  • Amitano, Sara
  • Roade, Luisa
  • FinnGen
  • The COVID-19 Host Genetics Initiative
  • Fava, Francesca
  • Spinner, Christoph D.
  • Prati, Daniele
  • Bernardo, David
  • García, Federico
  • Darcis, Gilles
  • Fernández-Cadenas, Israel
  • Holter, Jan Cato
  • Banales, Jesús M.
  • Frithiof, Robert
  • Kiryluk, Krzysztof
  • Duga, Stefano
  • Asselta, Rosanna
  • Costa Pereira, Alexandre de
  • Romero-Gómez, Manuel
  • Bujanda, Luis
  • Hov, Johannes R.
  • Migeotte, Isabelle
  • Renieri, Alessandra
  • Planas, Anna M.
  • Ludwig, Kerstin
  • Buti, María
  • Rahmouni, Souad
  • Alarcón-Riquelme, M. E.
  • Schulte, Eva C.
  • Franke, Andre
  • Karlsen, Tom H.
  • Valenti, Luca
  • Zeberg, Hugo
  • Richards, Brent
  • Ganna, Andrea
Background There is considerable variability in COVID-19 outcomes amongst younger adults—and some of this variation may be due to genetic predisposition. We characterized the clinical implications of the major genetic risk factor for COVID-19 severity, and its age-dependent effect, using individual-level data in a large international multi-centre consortium. Method The major common COVID-19 genetic risk factor is a chromosome 3 locus, tagged by the marker rs10490770. We combined individual level data for 13,424 COVID-19 positive patients (N=6,689 hospitalized) from 17 cohorts in nine countries to assess the association of this genetic marker with mortality, COVID-19-related complications and laboratory values. We next examined if the magnitude of these associations varied by age and were independent from known clinical COVID-19 risk factors. Findings We found that rs10490770 risk allele carriers experienced an increased risk of all-cause mortality (hazard ratio [HR] 1·4, 95% confidence interval [CI] 1·2–1·6) and COVID-19 related mortality (HR 1·5, 95%CI 1·3–1·8). Risk allele carriers had increased odds of several COVID-19 complications: severe respiratory failure (odds ratio [OR] 2·0, 95%CI 1·6-2·6), venous thromboembolism (OR 1·7, 95%CI 1·2-2·4), and hepatic injury (OR 1·6, 95%CI 1·2-2·0). Risk allele carriers ≤ 60 years had higher odds of death or severe respiratory failure (OR 2·6, 95%CI 1·8-3·9) compared to those > 60 years OR 1·5 (95%CI 1·3-1·9, interaction p-value=0·04). Amongst individuals ≤ 60 years who died or experienced severe respiratory COVID-19 outcome, we found that 31·8% (95%CI 27·6-36·2) were risk variant carriers, compared to 13·9% (95%CI 12·6-15·2%) of those not experiencing these outcomes. Prediction of death or severe respiratory failure among those ≤ 60 years improved when including the risk allele (AUC 0·82 vs 0·84, p=0·016) and the prediction ability of rs10490770 risk allele was similar to, or better than, most established clinical risk factors. Interpretation The major common COVID-19 risk locus on chromosome 3 is associated with increased risks of morbidity and mortality—and these are more pronounced amongst individuals ≤ 60 years. The effect on COVID-19 severity was similar to, or larger than most established risk factors, suggesting potential implications for clinical risk management., AG has received support by NordForsk Nordic Trial Alliance (NTA) grant, by Academy of Finland Fellow grant N. 323116 and the Academy of Finland for PREDICT consortium N. 340541. The Richards research group is supported by the Canadian Institutes of Health Research (CIHR) (365825 and 409511), the Lady Davis Institute of the Jewish General Hospital, the Canadian Foundation for Innovation (CFI), the NIH Foundation, Cancer Research UK, Genome Quebec, the Public Health Agency of Canada, the McGill Interdisciplinary Initiative in Infection and Immunity and the Fonds de Recherche Quebec Sante (FRQS). TN is supported by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists. GBL is supported by a CIHR scholarship and a joint FRQS and Quebec Ministry of Health and Social Services scholarship. JBR is supported by an FRQS Clinical Research Scholarship. Support from Calcul Quebec and Compute Canada is acknowledged. TwinsUK is funded by the Welcome Trust, the Medical Research Council, the European Union, the National Institute for Health Research-funded BioResource and the Clinical Research Facility and Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London. The Biobanque Quebec COVID19 is funded by FRQS, Genome Quebec and the Public Health Agency of Canada, the McGill Interdisciplinary Initiative in Infection and Immunity and the Fonds de Recherche Quebec Sante. These funding agencies had no role in the design, implementation or interpretation of this study. The COVID19-Host(a)ge study received infrastructure support from the DFG Cluster of Excellence 2167 Precision Medicine in Chronic Inflammation (PMI) (DFG Grant: EXC2167). The COVID19-Host(a)ge study was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the Computational Life Sciences funding concept (CompLS grant 031L0165). Genotyping in COVID19-Host(a)ge was supported by a philantropic donation from Stein Erik Hagen. The COVID GWAs, Premed COVID-19 study (COVID19-Host(a)ge_3) was supported by Grupo de Trabajo en Medicina Personalizada contra el COVID-19 de Andalucia and also by the Instituto de Salud Carlos III (CIBERehd and CIBERER). Funding comes from COVID-19-GWAS, COVID-PREMED initiatives. Both of them are supported by Consejeria de Salud y Familias of the Andalusian Government. DMM is currently funded by the the Andalussian government (Proyectos Estrategicos-Fondos Feder PE-0451-2018). The Columbia University Biobank was supported by Columbia University and the National Center for Advancing Translational Sciences, NIH, through Grant Number UL1TR001873. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or Columbia University. The SPGRX study was supported by the Consejeria de Economia, Conocimiento, Empresas y Universidad #CV20-10150. The GEN-COVID study was funded by: the MIUR grant Dipartimenti di Eccellenza 2018-2020 to the Department of Medical Biotechnologies University of Siena, Italy; the Intesa San Paolo 2020 charity fund dedicated to the project NB/2020/0119; and philanthropic donations to the Department of Medical Biotechnologies, University of Siena for the COVID-19 host genetics research project (D.L n.18 of March 17, 2020). Part of this research project is also funded by Tuscany Region Bando Ricerca COVID-19 Toscana grant to the Azienda Ospedaliero Universitaria Senese (CUP I49C20000280002). Authors are grateful to: the CINECA consortium for providing computational resources; the Network for Italian Genomes (NIG) (http://www.nig.cineca.it) for its support; the COVID-19 Host Genetics Initiative (https://www.covid19hg.org/); the Genetic Biobank of Siena, member of BBMRI-IT, Telethon Network of Genetic Biobanks (project no. GTB18001), EuroBioBank, and RD-Connect, for managing specimens. Genetics against coronavirus (GENIUS), Humanitas University (COVID19-Host(a)ge_4) was supported by Ricerca Corrente (Italian Ministry of Health), intramural funding (Fondazione Humanitas per la Ricerca). The generous contribution of Banca Intesa San Paolo and of the Dolce&Gabbana Fashion Firm is gratefully acknowledged. Data acquisition and sample processing was supported by COVID-19 Biobank, Fondazione IRCCS Ca Granda Milano; LV group was supported by MyFirst Grant AIRC n.16888, Ricerca Finalizzata Ministero della Salute RF-2016-02364358, Ricerca corrente Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, the European Union (EU) Programme Horizon 2020 (under grant agreement No. 777377) for the project LITMUS- Liver Investigation: Testing Marker Utility in Steatohepatitis, Programme Photonics under grant agreement 101016726 for the project REVEAL: Neuronal microscopy for cell behavioural examination and manipulation, Fondazione Patrimonio Ca' Granda Liver Bible PR-0361. DP was supported by Ricerca corrente Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, CV PREVITAL Strategie di prevenzione primaria nella popolazione Italiana Ministero della Salute, and Associazione Italiana per la Prevenzione dell'Epatite Virale (COPEV). Genetic modifiers for COVID-19 related illness (BeLCovid_1) was supported by the Fonds Erasme. The Host genetics and immune response in SARS-Cov-2 infection (BelCovid_2) study was supported by grants from Fondation Leon Fredericq and from Fonds de la Recherche Scientifique (FNRS). The INMUNGEN-CoV2 study was funded by the Consejo Superior de Investigaciones Cientificas. KUL is supported by the German Research Foundation (LU 1944/3-1) SweCovid is funded by the SciLifeLab/KAW national COVID-19 research program project grant to Michael Hultstrom (KAW 2020.0182) and the Swedish Research Council to Robert Frithiof (2014-02569 and 2014-07606). HZ is supported by Jeansson Stiftelser, Magnus Bergvalls Stiftelse. The COMRI cohort is funded by Technical University of Munich, Munich, Germany. Genotyping for the COMRI cohort was performed and funded by the Genotyping Laboratory of Institute for Molecular Medicine Finland FIMM Technology Centre, University of Helsinki, Helsinki, Finland., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

  • Degenhardt, Frauke
  • Ellinghaus, David
  • Juzenas, Simonas
  • Lerga-Jaso, Jon
  • Wendorff, Mareike
  • Maya-Miles, Douglas
  • Uellendahl-Werth, Florian
  • ElAbd, Hesham
  • Rühlemann, Malte C.
  • Arora, Jatin
  • Özer, Onur
  • Morilla Romero de la Osa, R.
  • Paccapelo, Cinzia
  • Lehmann, Clara
  • Angelini, Claudio
  • Cappadona, Claudio
  • Garrido Chercoles, Adolfo
  • Azuure, Clinton
  • Riveiro-Barciela, Mar
  • COVICAT study group
  • Rosenstiel, Philip
  • Santoro, Luigi
  • Solligård, Erik
  • Covid-19 Aachen Study (COVAS)
  • Myhre, Ronny
  • Bianco, Cristiana
  • Badalamenti, Salvatore
  • Cea, Cristina
  • Müller, Fredrik
  • Sander, Leif Erik
  • Hemmrich-Stanisak, Georg
  • Bellani, Giacomo
  • Bacher, Petra
  • Toapanta, David
  • Grasselli, Giacomo
  • Pezzoli, Gianni
  • Costantino, Giorgio
  • Vadla, May Sissel
  • Albano, Giovanni
  • Niemi, Mari
  • Buti, María
  • Cardamone, Giulia
  • Valsecchi, Maria Grazia
  • Koehler, Philipp
  • Lippert, Lena J.
  • Salazar, Adolfo de
  • Bellelli, Giuseppe
  • Citerio, Giuseppe
  • Foti, Giuseppe
  • Lamorte, Giuseppe
  • Matullo, Giuseppe
  • Baselli, Guido
  • Kurihara, Hayato
  • Neb, Holger
  • Tran, Florian
  • Duga, Stefano
  • Klein, Sebastian
  • Contro, Ernesto
  • Wacker, Eike M.
  • Gutiérrez-Stampa, María A.
  • Ciesek, Sandra
  • My, Ilaria
  • Kurth, Ingo
  • Hernández, Isabel
  • Pink, Isabell
  • Zoller, Heinz
  • Rojas, Itziar de
  • Galván-Femenia, Iván
  • Holter, Jan Cato
  • Schommers, Philipp
  • Hernández-Tejero, María
  • Bujanda, Luis
  • Afset, Jan Egil
  • Heyckendorf, Jan
  • Kässens, Jan
  • May, Sandra
  • Binatti, Eleonora
  • Carrabba, Maria
  • Wienbrandt, Lars
  • Damås, Jan Kristian
  • Rybniker, Jan
  • Suwalski, Phillip
  • Altmüller, Janine
  • Vehreschild, Maria J. G. T.
  • Ampuero, Javier
  • Ceriotti, Ferruccio
  • Martín, Javier
  • Schulte, Eva C.
  • Erdmann, Jeanette
  • Banales, Jesús M.
  • Badia, Joan Ramon
  • Bombace, Sara
  • Dopazo, Joaquín
  • Pablo, Raúl de
  • Figuera Basso, Maria E.
  • Schneider, Jochen
  • Lihaug Hoff, Dag Arne
  • Blandino Ortiz, Aaron
  • García Sánchez, Félix
  • Bergan, Jonas
  • Hov, Johannes R.
  • Barretina, Jordi
  • Walter, Jörn
  • Hernández Quero, José
  • Goikoetxea-Aguirre, Josune
  • Navas, Enrique
  • Delgado, Juan
  • Marsal, Sara
  • Guerrero, Juan M.
  • Heidecker, Bettina
  • Roade, Luisa
  • Fazaal, Julia
  • Casalone, Elisabetta
  • Kraft, Julia
  • Lenz, Tobias L.
  • Schröder, Julia
  • Manunta, Maria
  • Ferrer, Ricard
  • Acosta-Herrera, Marialbert
  • D’Angiò, Mariella
  • Heggelund, Lars
  • Baldini, Marina
  • Cazzaniga, Marina
  • Grimsrud, Marit M.
  • Urrechaga, Eloisa
  • Cornberg, Markus
  • Pelusi, Serena
  • Galimberti, Daniela
  • García-Fernández, Alba-Estela
  • Volland, Sonja
  • Bals, Robert
  • Calderón, Enrique J.
  • Nöthen, Markus M.
  • Marquié, Marta
  • Castoldi, Massimo
  • Cordioli, Mattia
  • Cecconi, Maurizio
  • D’Amato, Mauro
  • Augustin, Max
  • Tomasi, Melissa
  • Prati, Daniele
  • Franke, Andre
  • Palom, Adriana
  • Paraboschi, Elvezia Maria
  • Bandera, Alessandra
  • Braun, Alice
  • Boada, Mercè
  • Dreher, Michael
  • Blanco-Grau, Albert
  • Seilmaier, Michael J.
  • Joannidis, Michael
  • Wittig, Michael
  • Mazzocco, Michela
  • Ludwig, Kerstin U.
  • Brunak, Søren
  • Haschka, David
  • Ciccarelli, Michele
  • Rodríguez-Gandía, Miguel
  • Bocciolone, Monica
  • Cid, Rafael de
  • Wilfling, Sibylle
  • Pontali, Emanuele
  • Miozzo, Monica
  • Imaz Ayo, Natale
  • Ramírez, Alfredo
  • Blay, Natalia
  • Raychaudhuri, Soumya
  • Mantovani, Alberto
  • Berger, Marc M.
  • Chueca, Natalia
  • Montano, Nicola
  • Braun, Nicole
  • Ludwig, Nicole
  • Valenti, Luca
  • Marx, Nikolaus
  • Fernández, Javier
  • Bosari, Silvano
  • Martínez, Nilda
  • Risnes, Kari
  • Reverter, Enric
  • Norwegian SARS-CoV-2 Study group
  • Jiménez, David
  • Cornely, Oliver A.
  • Witzke, Oliver
  • Palmieri, Orazio
  • Zanella, Alberto
  • Téllez, Luis
  • Pa COVID-19 Study Group
  • Karlsen, Tom H.
  • Faverio, Paola
  • Haider, Sammra
  • Preatoni, Paoletta
  • Terranova, Leonardo
  • Bonfanti, Paolo
  • Pestaña, David
  • Omodei, Paolo
  • Schreiber, Stefan
  • Romero-Gómez, Manuel
  • Heilmann-Heimbach, Stefanie
  • Aliberti, Stefano
  • Ripke, Stephan
  • Dudman, Susanne
  • Cherubini, Alessandro
  • Nkambule, Lindokuhle
  • Wesse, Tanja
  • Nebel, Almut
  • Banasik, Karina
  • Lenning, Ole Bernt
  • Teles, Ana
  • Albillos, Agustín
  • Zheng, Tenghao
  • The Humanitas COVID-19 Task Force
  • The Humanitas Gavazzeni COVID-19 Task Force
  • Bahmer, Thomas
  • Eggermann, Thomas
  • Illig, Thomas
  • Brenner, Thorsten
  • Pumarola, Tomàs
  • Müller, Karl Erik
  • Scarpini, Elio
  • Knopp, Lisa
  • Martinelli-Boneschi, Filippo
  • Medrano, Francisco Javier
  • Feldt, Torsten
  • Protti, Alessandro
  • Arana-Arri, Eunate
  • Folseraas, Trine
  • Gonzalez Cejudo, Trinidad
  • Landmesser, Ulf
  • Protzer, Ulrike
  • Kildal, Anders Benjamin
  • Gaede, Karoline I.
  • Hehr, Ute
  • Rimoldi, Valeria
  • Monzani, Valter
  • Muñiz-Diaz, Eduardo
  • Barreira, Ana
  • Gustad, Lise Tuset
  • Skogen, Vegard
  • Keitel, Verena
  • Kopfnagel, Verena
  • Biondi, Andrea
  • Aziz, Fátima
  • Pigazzini, Sara
  • Aghemo, Alessio
  • Friaza Patiño, Vicente
  • Andrade, Victor
  • Moreno, Victor
  • Azzolini, Elena
  • Albrecht, Wolfgang
  • Lleo, Ana
  • Peter, Wolfgang
  • Tentorio, Paolo
  • Garbarino, Lucia
  • Poller, Wolfgang
  • García-Etxebarria, Koldo
  • Farré, Xavier
  • Yi, Xiaoli
  • Wang, Xiaomin
  • García, Federico
  • Khodamoradi, Yascha
  • Sandoval, Elena
  • Gerussi, Alessio
  • Asselta, Rosanna
  • Karadeniz, Zehra
  • Gualtierotti, Roberta
  • Latiano, Anna
  • Tonby, Kristian
  • Goerg, Siegfried
  • Caballero-Garralda, Andrea
  • Ganna, Andrea
  • Gori, Andrea
  • Glück, Andreas
  • Lind, Andreas
  • Peyvandi, Flora
  • Gallego-Durán, Rocío
  • Tanck, Anja
  • Mesonero, Francisco
  • Castro Blázquez, Pedro
  • Helbig, Elisa T.
  • Sancho, Cristina
  • Hinney, Anke
  • Carreras Nolla, Anna
  • Fracanzani, Anna Ludovica
  • Peschuck, Anna
  • Cavallero, Annalisa
  • Dyrhol-Riise, Anne Ma
  • Ruello, Antonella
  • Julià, Antonio
  • Rodrigues, Pedro M.
  • Nieto Liñán, Rosa María
  • Schaefer, Marco
  • Ruiz, Agustín
  • Muscatello, Antonio
  • Kurth, Florian
  • Ostadreza, Mahnoosh
  • Pesenti, Antonio
  • Voza, Antonio
  • Rando-Segura, Ariadna
  • Solier-López, Aurora
  • España, Pedro Pablo
  • Schmidt, Axel
  • Cortes, Beatriz
  • Mateos, Beatriz
  • Izquierdo-Sanchez, Laura
  • Rodríguez-Frías, Francisco
  • Carpani, Rossana
  • Nafría-Jiménez, Beatriz
  • Schaefer, Benedikt
  • Jensen, Björn
  • Intxausti, Maider
  • Cáceres, Mario
  • Blasi, Francesco
  • Bellinghausen, Carla
  • Maj, Carlo
  • Ferrando, Carlos
  • Rachele Bettini, Laura
  • Horra, Carmen de la
  • Hanses, Frank
  • Quereda, Carmen
  • Mayer, Alena
  • Skurk, Carsten
  • Hoffmann, Per
  • Thibeault, Charlotte
  • Scollo, Chiara
  • Herr, Christian
  • Kogevinas, Manolis
  • Spinner, Christoph D.
  • Sumoy, Lauro
  • Malvestiti, Francesco
  • Gassner, Christoph
  • Invernizzi, Pietro
  • Lange, Christoph
  • Holten, Aleksander Rygh
  • Hu, Cinzia
Given the highly variable clinical phenotype of Coronavirus disease 2019 (COVID-19), a deeper analysis of the host genetic contribution to severe COVID-19 is important to improve our understanding of underlying disease mechanisms. Here, we describe an extended GWAS meta-analysis of a well-characterized cohort of 3,260 COVID-19 patients with respiratory failure and 12,483 population controls from Italy, Spain, Norway and Germany/Austria, including stratified analyses based on age, sex and disease severity, as well as targeted analyses of chromosome Y haplotypes, the human leukocyte antigen (HLA) region and the SARS-CoV-2 peptidome. By inversion imputation, we traced a reported association at 17q21.31 to a highly pleiotropic ∼0.9-Mb inversion polymorphism and characterized the potential effects of the inversion in detail. Our data, together with the 5th release of summary statistics from the COVID-19 Host Genetics Initiative, also identified a new locus at 19q13.33, including NAPSA, a gene which is expressed primarily in alveolar cells responsible for gas exchange in the lung., Andre Franke and David Ellinghaus were supported by a grant from the German Federal Ministry of Education and Research (01KI20197), Andre Franke, David Ellinghaus and Frauke Degenhardt were supported by the Deutsche Forschungsgemeinschaft Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC2167). David Ellinghaus was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the Computational Life Sciences funding concept (CompLS grant 031L0165). David Ellinghaus, Karina Banasik and Søren Brunak acknowledge the Novo Nordisk Foundation (grant NNF14CC0001 and NNF17OC0027594). Tobias L. Lenz, Ana Teles and Onur Özer were funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project numbers 279645989; 433116033; 437857095. Mareike Wendorff and Hesham ElAbd are supported by the German Research Foundation (DFG) through the Research Training Group 1743, "Genes, Environment and Inflammation". This project was supported by a Covid-19 grant from the German Federal Ministry of Education and Research (BMBF; ID: 01KI20197). Luca Valenti received funding from: Ricerca Finalizzata Ministero della Salute RF2016-02364358, Italian Ministry of Health ""CV PREVITAL – strategie di prevenzione primaria cardiovascolare primaria nella popolazione italiana; The European Union (EU) Programme Horizon 2020 (under grant agreement No. 777377) for the project LITMUS- and for the project ""REVEAL""; Fondazione IRCCS Ca' Granda ""Ricerca corrente"", Fondazione Sviluppo Ca' Granda ""Liver-BIBLE"" (PR-0391), Fondazione IRCCS Ca' Granda ""5permille"" ""COVID-19 Biobank"" (RC100017A). Andrea Biondi was supported by the grant from Fondazione Cariplo to Fondazione Tettamanti: "Biobanking of Covid-19 patient samples to support national and international research (Covid-Bank). This research was partly funded by a MIUR grant to the Department of Medical Sciences, under the program "Dipartimenti di Eccellenza 2018–2022". This study makes use of data generated by the GCAT-Genomes for Life. Cohort study of the Genomes of Catalonia, Fundació IGTP. IGTP is part of the CERCA Program / Generalitat de Catalunya. GCAT is supported by Acción de Dinamización del ISCIIIMINECO and the Ministry of Health of the Generalitat of Catalunya (ADE 10/00026); the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017-SGR 529). Marta Marquié received research funding from ant PI19/00335 Acción Estratégica en Salud, integrated in the Spanish National RDI Plan and financed by ISCIIISubdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa")., Beatriz Cortes is supported by national grants PI18/01512. Xavier Farre is supported by VEIS project (001-P-001647) (cofunded by European Regional Development Fund (ERDF), “A way to build Europe”). Additional data included in this study was obtained in part by the COVICAT Study Group (Cohort Covid de Catalunya) supported by IsGlobal and IGTP, EIT COVID-19 Rapid Response activity 73A and SR20-01024 La Caixa Foundation. Antonio Julià and Sara Marsal were supported by the Spanish Ministry of Economy and Competitiveness (grant numbers: PSE-010000-2006-6 and IPT-010000-2010-36). Antonio Julià was also supported the by national grant PI17/00019 from the Acción Estratégica en Salud (ISCIII) and the FEDER. The Basque Biobank is a hospitalrelated platform that also involves all Osakidetza health centres, the Basque government's Department of Health and Onkologikoa, is operated by the Basque Foundation for Health Innovation and Research-BIOEF. Mario Cáceres received Grants BFU2016-77244-R and PID2019-107836RB-I00 funded by the Agencia Estatal de Investigación (AEI, Spain) and the European Regional Development Fund (FEDER, EU). Manuel Romero Gómez, Javier Ampuero Herrojo, Rocío Gallego Durán and Douglas Maya Miles are supported by the “Spanish Ministry of Economy, Innovation and Competition, the Instituto de Salud Carlos III” (PI19/01404, PI16/01842, PI19/00589, PI17/00535 and GLD19/00100), and by the Andalussian government (Proyectos Estratégicos-Fondos Feder PE-0451-2018, COVID-Premed, COVID GWAs). The position held by Itziar de Rojas Salarich is funded by grant FI20/00215, PFIS Contratos Predoctorales de Formación en Investigación en Salud. Enrique Calderón's team is supported by CIBER of Epidemiology and Public Health (CIBERESP), "Instituto de Salud Carlos III". Jan Cato Holter reports grants from Research Council of Norway grant no 312780 during the conduct of the study. Dr. Solligård: reports grants from Research Council of Norway grant no 312769. The BioMaterialBank Nord is supported by the German Center for Lung Research (DZL), Airway Research Center North (ARCN). The BioMaterialBank Nord is member of popgen 2.0 network (P2N). Philipp Koehler has received non-financial scientific grants from Miltenyi Biotec GmbH, Bergisch Gladbach, Germany, and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany. He is supported by the German Federal Ministry of Education and Research (BMBF)., Oliver A. Cornely is supported by the German Federal Ministry of Research and Education and is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy – CECAD, EXC 2030 – 390661388. The COMRI cohort is funded by Technical University of Munich, Munich, Germany. Genotyping was performed by the Genotyping laboratory of Institute for Molecular Medicine Finland FIMM Technology Centre, University of Helsinki. This work was supported by grants of the Rolf M. Schwiete Stiftung, the Saarland University, BMBF and The States of Saarland and Lower Saxony. Kerstin U. Ludwig is supported by the German Research Foundation (DFG, LU-1944/3-1). Genotyping for the BoSCO study is funded by the Institute of Human Genetics, University Hospital Bonn. Frank Hanses was supported by the Bavarian State Ministry for Science and Arts. Part of the genotyping was supported by a grant to Alfredo Ramirez from the German Federal Ministry of Education and Research (BMBF, grant: 01ED1619A, European Alzheimer DNA BioBank, EADB) within the context of the EU Joint Programme – Neurodegenerative Disease Research (JPND). Additional funding was derived from the German Research Foundation (DFG) grant: RA 1971/6-1 to Alfredo Ramirez. Philip Rosenstiel is supported by the DFG (CCGA Sequencing Centre and DFG ExC2167 PMI and by SH state funds for COVID19 research). Florian Tran is supported by the Clinician Scientist Program of the Deutsche Forschungsgemeinschaft Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC2167). Christoph Lange and Jan Heyckendorf are supported by the German Center for Infection Research (DZIF). Thorsen Brenner, Marc M Berger, Oliver Witzke und Anke Hinney are supported by the Stiftung Universitätsmedizin Essen. Marialbert Acosta-Herrera was supported by Juan de la Cierva Incorporacion program, grant IJC2018-035131-I funded by MCIN/AEI/10.13039/501100011033. Eva C Schulte is supported by the Deutsche Forschungsgemeinschaft (DFG; SCHU 2419/2-1)., No